These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [A double-blind study of the effect of L-dopa in psychotic patients with tardive dyskinesia]. Karniol IG; Giampietro AC; Moura DS; Vilela WA; Oliveira MA; Zuardi AW Acta Psiquiatr Psicol Am Lat; 1983 Dec; 29(4):261-6. PubMed ID: 6369888 [TBL] [Abstract][Full Text] [Related]
13. Treatment of tardive dyskinesia. Roos RA; Buruma OJ; de Wolff FA Clin Neuropharmacol; 1988 Aug; 11(4):386. PubMed ID: 3061638 [No Abstract] [Full Text] [Related]
14. Naloxone may be beneficial in the treatment of tardive dyskinesia. Blum I; Munitz H; Shalev A; Roberts E Clin Neuropharmacol; 1984; 7(3):265-7. PubMed ID: 6386154 [No Abstract] [Full Text] [Related]
15. Baclofen in the treatment of tardive dyskinesia. Nair NP; Yassa R; Ruiz-Navarro J; Schwartz G Am J Psychiatry; 1978 Dec; 135(12):1562-3. PubMed ID: 31097 [No Abstract] [Full Text] [Related]
17. Naloxone in tardive dyskinesia. Blum I; Nisipeanu PF; Roberts E Psychopharmacology (Berl); 1987; 93(4):538. PubMed ID: 3124188 [No Abstract] [Full Text] [Related]
18. [A controlled study on the treatment of tardive dyskinesia using 1-stepholidine]. Cai N Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):281-3, 319. PubMed ID: 3069384 [No Abstract] [Full Text] [Related]
19. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study. Jus A; Villeneuve A; Gautier J; Jus K; Villeneuve C; Pires P; Villeneuve R Neuropsychobiology; 1978; 4(3):140-9. PubMed ID: 340975 [TBL] [Abstract][Full Text] [Related]
20. Double-blind evaluation of deanol in tardive dyskinesia. Penovich P; Morgan JP; Kerzner B; Karch F; Goldblatt D JAMA; 1978 May; 239(19):1997-8. PubMed ID: 347112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]